Researchers showed that arming cytokine-induced memory-like NK cells with a neoepitope-specific CAR significantly enhanced their antitumor responses to nucleophosphmin-1 (NPM1)-mutated acute myeloid leukemia while avoiding off-target toxicity.
[Proceedings of the National Academy of Sciences of the United States of America]